Evidence map›Paper›PMID 28381559›Full record

ArticleThe Journal of biological chemistry2017

Identification of a signaling cascade that maintains constitutive δ-opioid receptor incompetence in peripheral sensory neurons.

Allison Doyle Brackley, Shayda Sarrami, Ruben Gomez, Kristi A Guerrero, Nathaniel A Jeske

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. GRK2 activates TRAF2-NF-Acta pharmaceutica Sinica. B · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Targeting G protein-coupled receptor kinases (GRKs) to G protein-coupled receptors.Current opinion in endocrine and metabolic research · 2021
    Article
  9. Article
  10. Alleviating pain with delta opioid receptor agonists: evidence from experimental models.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Allison Doyle BrackleyFrom the Departments of Pharmacology.
Shayda SarramiOral and Maxillofacial Surgery, and.
Ruben GomezOral and Maxillofacial Surgery, and.
Kristi A GuerreroOral and Maxillofacial Surgery, and.
Nathaniel A JeskeFrom the Departments of Pharmacology, Jeske@uthscsa.edu.
National Medical Research Center of Dentistry and Maxillofacial Surgery · RUThe University of Texas Health Science Center at San Antonio · US

Funding

Institutional Research Training GrantT32DE014318 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Kenneth M Hargreaves · 2002 to 2026
$12.1M
PATHOBIOLOGY OF OCCLUSIVE VASCULAR DISEASET32HL007446 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Jean Chrisostome Bopassa · 1985 to 2026
$8.9M
Scaffolding the Transition to Chronic PainR01NS082746 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JESKE, NATHANIEL AARON · 2013 to 2017
$1.7M
A mechanism for delta opioid receptor primingF31DE025551 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BRACKLEY, ALLISON DOYLE · 2015 to 2016
$65k
NHLBI NIH HHS T32 HL007446NIDCR NIH HHS F31 DE025551NIDCR NIH HHS T32 DE014318NINDS NIH HHS R01 NS082746
6 · The paper itself

Abstract

μ-Opioid receptor (MOR) agonists are often used to treat severe pain but can result in adverse side effects. To circumvent systemic side effects, targeting peripheral opioid receptors is an attractive alternative treatment for severe pain. Activation of the δ-opioid receptor (DOR) produces similar analgesia with reduced side effects. However, until primed by inflammation, peripheral DOR is analgesically incompetent, raising interest in the mechanism. We recently identified a novel role for G-protein-coupled receptor kinase 2 (GRK2) that renders DOR analgesically incompetent at the plasma membrane. However, the mechanism that maintains constitutive GRK2 association with DOR is unknown. Protein kinase A (PKA) phosphorylation of GRK2 at Ser-685 targets it to the plasma membrane. Protein kinase A-anchoring protein 79/150 (AKAP), residing at the plasma membrane in neurons, scaffolds PKA to target proteins to mediate downstream signal. Therefore, we sought to determine whether GRK2-mediated DOR desensitization is directed by PKA via AKAP scaffolding. Membrane fractions from cultured rat sensory neurons following AKAP siRNA transfection and from AKAP-knock-out mice had less PKA activity, GRK2 Ser-685 phosphorylation, and GRK2 plasma membrane targeting than controls. Site-directed mutagenesis revealed that GRK2 Ser-685 phosphorylation drives the association of GRK2 with plasma membrane-associated DOR. Moreover, overexpression studies with AKAP mutants indicated that impaired AKAP-mediated PKA scaffolding significantly reduces DOR-GRK2 association at the plasma membrane and consequently increases DOR activity in sensory neurons without a priming event. These findings suggest that AKAP scaffolds PKA to increase plasma membrane targeting and phosphorylation of GRK2 to maintain DOR analgesic incompetence in peripheral sensory neurons.

Indexed as

Signal TransductionA Kinase Anchor ProteinsAnimalsCattleCell MembraneCyclic AMP-Dependent Protein KinasesG-Protein-Coupled Receptor Kinase 2MaleMicePhosphorylationRatsRats, Sprague-DawleyReceptors, Opioid, deltaSensory Receptor CellsA Kinase Anchor ProteinsCyclic AMP-Dependent Protein KinasesG-Protein-Coupled Receptor Kinase 2GRK2 protein, mouseGrk2 protein, ratReceptors, Opioid, deltaA-kinase anchoring protein (AKAP)G-protein-coupled receptor (GPCR)GRK2neuronopiate opioidopioidpainphosphorylationprotein kinase A (PKA)

Identifiers

PMID28381559
PMCPMC5448103
OpenAlexW2605123088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.